Search Results

Raltegravir 50mg 50mg  | Purity Not Available

Adooq Bioscience

Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.

More Information Supplier Page

Raltegravir 5mg 5mg  | Purity Not Available

Adooq Bioscience

Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.

More Information Supplier Page

Raltegravir 100mg 100mg  | Purity Not Available

Adooq Bioscience

Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.

More Information Supplier Page

Raltegravir 10mg 10mg  | Purity Not Available

Adooq Bioscience

Raltegravir (MK-0518) targets integrase, an HIV enzyme that integrates the viral genetic material into human chromosomes, a critical step in the pathogenesis of HIV.

More Information Supplier Page

Raf265 derivative 50mg 50mg  | Purity Not Available

Adooq Bioscience

Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 ??M.

More Information Supplier Page

Raf265 derivative 5mg 5mg  | Purity Not Available

Adooq Bioscience

Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 ??M.

More Information Supplier Page

Raf265 derivative 25mg 25mg  | Purity Not Available

Adooq Bioscience

Raf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 ??M.

More Information Supplier Page